Much of the coverage of COVID immunity often focuses on antibody response and for good reason - these small, y-shaped proteins can detect, and in some cases neutralise, viruses like SARS-CoV-2. But as variants like Omicron evolve to evade antibodies, the role of another part of the immune system, T cells, has been brought into sharper focus. These immune cells work in a different way to antibodies, attacking infected cells rather than the virus itself, which can make their response broader and more robust. Now, research is showing that, unlike antibodies, T cell potency is not impacted by the mutations in variants like Omicron. In this episode of Coronapod, we ask why T cells are so often overlooked, and what role they might be playing in our protection from the coronavirus.News:‘Killer’ immune cells still recognize Omicron variantSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.
Hosted on Acast. See acast.com/privacy for more information.
Fler avsnitt av Nature Podcast
Visa alla avsnitt av Nature PodcastNature Podcast med Springer Nature Limited finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
